These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6781885)

  • 1. Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum.
    Zimmerman CL; Patel IH; Levy RH; Edwards D; Nelson SD; Hutchinson M
    Epilepsia; 1981 Feb; 22(1):11-7. PubMed ID: 6781885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids.
    Patel IH; Levy RH
    Epilepsia; 1979 Feb; 20(1):85-90. PubMed ID: 369855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin.
    Mendel CM; Frost PH; Cavalieri RR
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1394-9. PubMed ID: 3782424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid.
    Riva R; Albani F; Contin M; Baruzzi A; Altomare M; Merlini GP; Perucca E
    Ther Drug Monit; 1984; 6(1):25-30. PubMed ID: 6424276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic interaction between valproic acid and free fatty acids in rhesus monkeys.
    Johno I; Huang MY; Levy RH
    Epilepsia; 1982 Dec; 23(6):649-56. PubMed ID: 6816579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum.
    Albani F; Riva R; Procaccianti G; Baruzzi A; Perucca E
    Epilepsia; 1983 Feb; 24(1):65-73. PubMed ID: 6401631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein binding of valproic acid in fetus-mother pairs throughout pregnancy: correlation with oxytocin administration and albumin and free fatty acid concentrations.
    Nau H; Krauer B
    J Clin Pharmacol; 1986 Mar; 26(3):215-21. PubMed ID: 3082943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes in valproic acid binding to rat serum proteins in vitro.
    Slattum PW; Cato AE; Pollack GM; Brouwer KL
    J Pharm Sci; 1996 Apr; 85(4):373-6. PubMed ID: 8901071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transplacental binding of valproic acid: influence of free fatty acids.
    Albani F; Riva R; Contin M; Baruzzi A; Altomare M; Merlini GP; Perucca E
    Br J Clin Pharmacol; 1984 Jun; 17(6):759-62. PubMed ID: 6430314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.
    Riva R; Albani F; Baruzzi A; Galvani I; Perucca E
    Ther Drug Monit; 1982; 4(4):341-52. PubMed ID: 6818733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.
    Gatti G; Crema F; Attardo-Parrinello G; Fratino P; Aguzzi F; Perucca E
    Ther Drug Monit; 1987 Dec; 9(4):389-91. PubMed ID: 3122377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites.
    Nau H; Helge H; Luck W
    J Pediatr; 1984 Apr; 104(4):627-34. PubMed ID: 6423793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.
    Semmes RL; Shen DD
    Pharm Res; 1990 May; 7(5):461-7. PubMed ID: 2114617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of intravenously administered intralipid on free fatty acid concentration and albumin binding capacity to bilirubin in newborn infants.
    Zoban P; Tomásová H; Mydlil V; Karas J; Michková E
    Czech Med; 1989; 12(2):68-77. PubMed ID: 2504562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal oscillations in plasma protein binding of valproic acid.
    Patel IH; Venkataramanan R; Levy RH; Viswanathan CT; Ojemann LM
    Epilepsia; 1982 Jun; 23(3):283-90. PubMed ID: 6806086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma free fatty acid turnover and oxidation during fat-free and intralipid TPN.
    Skutches CL; Myers RN; Paul P; Smink RD; Reichard GA
    JPEN J Parenter Enteral Nutr; 1980; 4(6):572-4. PubMed ID: 6780710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished protein binding capacity of uremic sera for valproate following hemodialysis: role of free fatty acids and uremic compounds.
    Dasgupta A; Jacques M; Malhotra D
    Am J Nephrol; 1996; 16(4):327-33. PubMed ID: 8739287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB.
    Richieri GV; Anel A; Kleinfeld AM
    Biochemistry; 1993 Jul; 32(29):7574-80. PubMed ID: 8338853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.